AC-262-536-600mg Accadrine 10mg Capsule In Pakistan
AC-262-536-600mg Accadrine 10mg Capsule In Pakistan | MyTelestore.com
AC-262-536 (Accadrine) 10mg Capsules contain AC-262-536, an investigational androgen-receptor-modulating compound studied primarily in preclinical research. It is sometimes marketed alongside SARMs, but it should not be presented as an approved dietary supplement or established medical treatment.
The stated 600mg should be verified against the original packaging, as it may refer to total product contents or another formulation specification rather than 600mg of active AC-262-536.
Product Overview
- Product: AC-262-536 / Accadrine
- Stated Strength: 10mg per capsule
- Stated Total Amount: 600mg
- Active Compound: AC-262-536
- Category: Investigational / research compound
- Form: Capsule
- Availability: Pakistan
What Is AC-262-536?
AC-262-536 is an investigational compound developed to interact with androgen receptors. It has primarily been examined in laboratory and preclinical research.
Because human clinical evidence is limited, available research does not establish AC-262-536 as safe or effective for bodybuilding, muscle growth, performance enhancement, or treatment of medical conditions.
Research Areas
Preclinical research involving androgen-receptor-modulating compounds such as AC-262-536 has examined areas including:
- Androgen-receptor activity
- Muscle and lean-tissue mechanisms
- Bone-related pathways
- Potential therapeutic applications under investigation
These research areas should not be interpreted as proof of safety or effectiveness for self-directed human use.
Important Safety Information
AC-262-536 is not an approved general-purpose dietary supplement or established prescription treatment.
Because human safety data are limited, potential risks and long-term effects have not been adequately established. Compounds that interact with androgen receptors may potentially affect:
- Natural hormone production
- Cholesterol and lipid levels
- Liver function
- Endocrine balance
- Cardiovascular health
The actual risk profile of AC-262-536 in humans remains uncertain.
